FBRX · Categories · Form 4

FBRX - SEC Form 4 insider transactions

Forte Biosciences Inc. (FBRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FBRX

• 5d
  Director Kornfeld Steven closing all direct ownership in the company (SEC Form 4) to cover withholding tax

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  SEC Form 4 filed by Director Brun Scott C. to cover withholding tax

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  Director Gryska David W closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  SEC Form 4 filed by Director Vincent Richard G to satisfy withholding tax

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  SEC Form 4 filed by Director Finck Barbara K (withholding obligation)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh to cover taxes

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  SEC Form 4 filed by Director Doberstein Stephen K to cover taxes

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  CHIEF FINANCIAL OFFICER Riley Antony A closing all direct ownership in the company (SEC Form 4) to satisfy withholding obligation

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 5d
  Officer Wagner Paul A. closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 57d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 134 shares, increasing direct ownership by 0.57% to 42,600 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 58d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 1% to 85,482 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 76d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 76d
  SEC Form 4 filed by Officer Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 91d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 152d
  SEC Form 4 filed by Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 152d
  SEC Form 4 filed by Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 231d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 231d
  SEC Form 4 filed by Officer Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 242d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 83,178 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 334d
  CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 134 shares and converted options into 375 shares, increasing direct ownership by 0.76% to 31,840 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 334d
  Officer Wagner Paul A. covered exercise/tax liability with 98 shares and converted options into 1,250 shares, increasing direct ownership by 1% to 82,092 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 425d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 134 shares, increasing direct ownership by 0.77% to 31,599 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 425d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 1% to 80,940 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 517d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.71% to 31,218 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 517d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 18 shares, increasing direct ownership by 2% to 79,788 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Officer Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 529d
  SEC Form 4 filed by Director Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 607d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 375 shares and covered exercise/tax liability with 154 shares, increasing direct ownership by 0.72% to 30,997 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 607d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 164 shares, increasing direct ownership by 1% to 78,556 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 699d
  CHIEF FINANCIAL OFFICER Riley Antony A covered exercise/tax liability with 133 shares and converted options into 375 shares, increasing direct ownership by 3% to 8,262 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 699d
  Officer Wagner Paul A. converted options into 1,250 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 2% to 77,470 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 712d
  SEC Form 4 filed by Director Kapoor Shivpreet Singh

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 712d
  SEC Form 4 filed by Director Vincent Richard G

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Eichenfield Lawrence

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Gryska David W

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Kornfeld Steven

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Doberstein Stephen K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Williams Donald Allen

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 740d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 791d
  CHIEF FINANCIAL OFFICER Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 200,504 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 791d
  Officer Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,907,971 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 882d
  Riley Antony A converted options into 9,375 shares and covered exercise/tax liability with 3,345 shares, increasing direct ownership by 3% to 194,474 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 882d
  Wagner Paul A. converted options into 31,250 shares and covered exercise/tax liability with 2,453 shares, increasing direct ownership by 2% to 1,879,174 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 890d
  SEC Form 4 filed by Finck Barbara K

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 890d
  SEC Form 4 filed by Riley Antony A

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 890d
  SEC Form 4 filed by Wagner Paul A.

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)
• 972d
  Chen Hubert C converted options into 7,500 shares and covered exercise/tax liability with 3,073 shares, increasing direct ownership by 5% to 93,405 units (SEC Form 4)

  4 - Forte Biosciences, Inc. (0001419041) (Issuer)

Other FBRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends